[Pharmacotherapy of amyotrophic lateral sclerosis].
Jokelainen
M
M
Paijat-Hame Central Hospital, Lahti, Finland.
D000328:Adult; D000368:Aged; D000690:Amyotrophic Lateral Sclerosis / Q000175:diagnosis / Q000188:drug therapy*; D014151:Anti-Anxiety Agents / Q000008:administration & dosage; D018450:Disease Progression; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009020:Morphine / Q000008:administration & dosage; D018696:Neuroprotective Agents / Q000009:adverse effects*; D011379:Prognosis; D019782:Riluzole / Q000627:therapeutic use*; D012720:Severity of Illness Index; D013727:Terminal Care
D014151:Anti-Anxiety Agents; D018696:Neuroprotective Agents; D009020:Morphine; D019782:Riluzole